Trademark/Service Mark Application, Principal Register
PTO- 1478
Approved for use through 02/28/2021. OMB 0651-0009
U.S. Patent and Trademark Office; U.S. DEPARTMENT OF COMMERCE
Under the Paperwork Reduction Act of 1995, no persons are required to respond to a collection of information unless it contains a valid OMB control number
Trademark/Service Mark Application, Principal Register
The mark consists of standard characters, without claim to any particular font style, size, or color.
REGISTER
Principal
APPLICANT INFORMATION
*OWNER OF MARK
Innocoll Pharmaceuticals Limited
INTERNAL ADDRESS
Monksland
*MAILING ADDRESS
9 Block D, Monksland Business Park
*CITY
Athlone Co. Roscommon
*COUNTRY/REGION/JURISDICTION/U.S. TERRITORY
Ireland
*EMAIL ADDRESS
XXXX
LEGAL ENTITY INFORMATION
TYPE
limited company (ltd.)
STATE/COUNTRY/REGION/JURISDICTION/U.S. TERRITORY WHERE LEGALLY ORGANIZED
Ireland
GOODS AND/OR SERVICES AND BASIS INFORMATION
INTERNATIONAL CLASS
005
*IDENTIFICATION
Pharmaceutical, veterinary and sanitary preparations for the treatment of wounds, burns and surgery; dressings, foils, compresses, wadding,
foams, semi-liquid matrice, barriers being medical dressings, bandages for skin wounds, sponges impregnated with antiseptics, and all for medical use in or on the human or non-human animal body;
dressings, foils, medicated compresses, wadding, foams, semi-liquid matrices being dressings, barriers, bandages for skin wounds, sponges impregnated with antiseptics made from or incorporating
collagen all for medical use; collagen dressings, foils, medicated compresses, wadding, foams, semi-liquid matrices being medical dressings, barriers being medical dressings, surgical bandages, films
being surgical dressings, membranes being surgical dressings for medical use as a temporary dermoplasty; surgical implants made from collagen for use in skin repair and skin improvement; surgical
implants comprising collagen for wound management and pain relief
At this time, the applicant intends to rely on Section 44(e) as a basis for registration and requests that the application be suspended to await the
submission of the foreign registration. If ultimately the applicant does not rely on §44(e) as a basis for registration, a valid claim of priority may be retained.
INTERNATIONAL CLASS
010
*IDENTIFICATION
Medical implant device comprised of a collagen and extracellular matrix composition; supportive surgical and medical patches and implants for
use in skin repair and skin improvement; surgical and medical implant devices composed of collagen; collagen constructs for medical, surgical or veterinary purposes; collagen based surgical implants
for management of post-operative pain; collagen based surgical implants for wound management; surgical and medical implant devices composed of collagen for medical purposes
At this time, the applicant intends to rely on Section 44(e) as a basis for registration and requests that the application be suspended to await the
submission of the foreign registration. If ultimately the applicant does not rely on §44(e) as a basis for registration, a valid claim of priority may be retained.
INTERNATIONAL CLASS
042
*IDENTIFICATION
Medical and scientific research services in the field of collagen based drug delivery systems; medical and scientific research services for
medical, veterinary and pharmaceutical purposes, scientific research, namely, chemistry and biochemistry, consultancy services relating to scientific research into the development of medical and
surgical products, contract scientific research services, scientific research and development of medical and surgical products for others, laboratory scientific research services relating to medical
and surgical products, industrial analysis services, namely, collagen based analysis services for medical, veterinary and pharmaceutical purposes
At this time, the applicant intends to rely on Section 44(e) as a basis for registration and requests that the application be suspended to await the
submission of the foreign registration. If ultimately the applicant does not rely on §44(e) as a basis for registration, a valid claim of priority may be retained.
ATTORNEY INFORMATION
NAME
Camille M. Miller
ATTORNEY DOCKET NUMBER
INNC0019US/5
ATTORNEY BAR MEMBERSHIP NUMBER
XXX
YEAR OF ADMISSION
XXXX
U.S. STATE/ COMMONWEALTH/ TERRITORY
XX
FIRM NAME
Cozen O'Connor
INTERNAL ADDRESS
Suite 2800
STREET
1650 Market Street
CITY
Philadelphia
STATE
Pennsylvania
COUNTRY/REGION/JURISDICTION/U.S. TERRITORY
United States
ZIP/POSTAL CODE
19103
PHONE
215-665-7273
FAX
2157012273
EMAIL ADDRESS
cmiller@cozen.com
OTHER APPOINTED ATTORNEY
Melanie A. Miller, Ashley Kessler, Mayura Noordyke, Brianne L. Polito, Kevin Gibbs, Julie Dostal
DOMESTIC REPRESENTATIVE INFORMATION
NAME
Camille M. Miller
FIRM NAME
Cozen O'Connor
INTERNAL ADDRESS
Suite 2800
STREET
1650 Market Street
CITY
Philadelphia
STATE
Pennsylvania
COUNTRY/REGION/JURISDICTION/U.S. TERRITORY
United States
ZIP CODE
19103
PHONE
215-665-7273
FAX
2157012273
EMAIL ADDRESS
cmiller@cozen.com
CORRESPONDENCE INFORMATION
NAME
Camille M. Miller
PRIMARY EMAIL ADDRESS FOR CORRESPONDENCE
cmiller@cozen.com
SECONDARY EMAIL ADDRESS(ES) (COURTESY COPIES)
NOT PROVIDED
FEE INFORMATION
APPLICATION FILING OPTION
TEAS Standard
NUMBER OF CLASSES
3
APPLICATION FOR REGISTRATION PER CLASS
350
*TOTAL FEES DUE
1050
*TOTAL FEES PAID
1050
SIGNATURE INFORMATION
SIGNATURE
/Camille M. Miller/
SIGNATORY'S NAME
Camille M. Miller
SIGNATORY'S POSITION
attorney
SIGNATORY'S PHONE NUMBER
215-665-7273
DATE SIGNED
03/11/2021
SIGNATURE METHOD
Signed directly within the form
PTO- 1478
Approved for use through 02/28/2021. OMB 0651-0009
U.S. Patent and Trademark Office; U.S. DEPARTMENT OF COMMERCE
Under the Paperwork Reduction Act of 1995, no persons are required to respond to a collection of information unless it contains a valid OMB control number
Trademark/Service Mark Application, Principal Register
Serial Number:90573694
Filing Date:03/11/2021
To the Commissioner for Trademarks:
MARK: INNOCOLL BIOTHERAPEUTICS (Standard Characters, see mark)
The literal element of the mark consists of INNOCOLL BIOTHERAPEUTICS. The mark consists of standard characters, without claim to any particular font style, size, or color.
The applicant, Innocoll Pharmaceuticals Limited, a limited company (ltd.) legally organized under the laws of Ireland, having an address of
Monksland
9 Block D, Monksland Business Park
Athlone Co. Roscommon
Ireland
XXXX
requests registration of the trademark/service mark identified above in the United States Patent and Trademark Office on the Principal Register established by the Act of July 5, 1946 (15 U.S.C.
Section 1051 et seq.), as amended, for the following:
International Class 005: Pharmaceutical, veterinary and sanitary preparations for the treatment of wounds, burns and surgery; dressings, foils, compresses, wadding, foams, semi-liquid matrice,
barriers being medical dressings, bandages for skin wounds, sponges impregnated with antiseptics, and all for medical use in or on the human or non-human animal body; dressings, foils, medicated
compresses, wadding, foams, semi-liquid matrices being dressings, barriers, bandages for skin wounds, sponges impregnated with antiseptics made from or incorporating collagen all for medical use;
collagen dressings, foils, medicated compresses, wadding, foams, semi-liquid matrices being medical dressings, barriers being medical dressings, surgical bandages, films being surgical dressings,
membranes being surgical dressings for medical use as a temporary dermoplasty; surgical implants made from collagen for use in skin repair and skin improvement; surgical implants comprising collagen
for wound management and pain relief
Intent to Use: The applicant has a bona fide intention, and is entitled, to use the mark in commerce on or in connection with the identified goods/services.
Priority based on foreign filing: The applicant has a bona fide intention, and is entitled, to use the mark in commerce on or in connection with the identified goods/services and asserts a claim of
priority based on Ireland application number 2021/00566, filed 03/10/2021.
INTENT TO PERFECT 44(d) : At this time, the applicant intends to rely on Section 44(e) as a basis for registration and requests that the application be suspended to await the submission of the
foreign registration. If ultimately the applicant does not rely on §44(e) as a basis for registration, a valid claim of priority may be retained.
International Class 010: Medical implant device comprised of a collagen and extracellular matrix composition; supportive surgical and medical patches and implants for use in skin repair and
skin improvement; surgical and medical implant devices composed of collagen; collagen constructs for medical, surgical or veterinary purposes; collagen based surgical implants for management of
post-operative pain; collagen based surgical implants for wound management; surgical and medical implant devices composed of collagen for medical purposes
Intent to Use: The applicant has a bona fide intention, and is entitled, to use the mark in commerce on or in connection with the identified goods/services.
Priority based on foreign filing: The applicant has a bona fide intention, and is entitled, to use the mark in commerce on or in connection with the identified goods/services and asserts a claim of
priority based on Ireland application number 2021/00566, filed 03/10/2021.
INTENT TO PERFECT 44(d) : At this time, the applicant intends to rely on Section 44(e) as a basis for registration and requests that the application be suspended to await the submission of the
foreign registration. If ultimately the applicant does not rely on §44(e) as a basis for registration, a valid claim of priority may be retained.
International Class 042: Medical and scientific research services in the field of collagen based drug delivery systems; medical and scientific research services for medical, veterinary and
pharmaceutical purposes, scientific research, namely, chemistry and biochemistry, consultancy services relating to scientific research into the development of medical and surgical products, contract
scientific research services, scientific research and development of medical and surgical products for others, laboratory scientific research services relating to medical and surgical products,
industrial analysis services, namely, collagen based analysis services for medical, veterinary and pharmaceutical purposes
Intent to Use: The applicant has a bona fide intention, and is entitled, to use the mark in commerce on or in connection with the identified goods/services.
Priority based on foreign filing: The applicant has a bona fide intention, and is entitled, to use the mark in commerce on or in connection with the identified goods/services and asserts a claim of
priority based on Ireland application number 2021/00566, filed 03/10/2021.
INTENT TO PERFECT 44(d) : At this time, the applicant intends to rely on Section 44(e) as a basis for registration and requests that the application be suspended to await the submission of the
foreign registration. If ultimately the applicant does not rely on §44(e) as a basis for registration, a valid claim of priority may be retained.
The owner's/holder's proposed attorney information: Camille M. Miller. Other appointed attorneys are Melanie A. Miller, Ashley Kessler, Mayura Noordyke, Brianne L. Polito, Kevin Gibbs, Julie
Dostal. Camille M. Miller of Cozen O'Connor, is a member of the XX bar, admitted to the bar in XXXX, bar membership no. XXX, and the attorney(s) is located at
Suite 2800
1650 Market Street
Philadelphia, Pennsylvania 19103
United States
215-665-7273(phone)
2157012273(fax)
cmiller@cozen.com
The docket/reference number is INNC0019US/5.
Camille M. Miller submitted the following statement: The attorney of record is an active member in good standing of the bar of the highest court of a U.S. state, the District of Columbia, or any U.S.
Commonwealth or territory.
The applicant hereby appoints Camille M. Miller of Cozen O'Connor
1650 Market Street
Suite 2800
Philadelphia Pennsylvania 19103
United States
215-665-7273(phone)
2157012273(fax)
cmiller@cozen.com
as applicant's representative upon whom notice or process in the proceedings affecting the mark may be served.
The applicant's current Correspondence Information:
Camille M. Miller
PRIMARY EMAIL FOR CORRESPONDENCE: cmiller@cozen.com SECONDARY EMAIL ADDRESS(ES) (COURTESY COPIES): NOT PROVIDED
Requirement for Email and Electronic Filing: I understand that a valid email address must be maintained by the applicant owner/holder and the applicant owner's/holder's attorney, if appointed,
and that all official trademark correspondence must be submitted via the Trademark Electronic Application System (TEAS).
A fee payment in the amount of $1050 has been submitted with the application, representing payment for 3 class(es).
Declaration
Declaration Signature
Signature: /Camille M. Miller/ Date: 03/11/2021
Signatory's Name: Camille M. Miller
Signatory's Position: attorney
Signatory's Phone Number: 215-665-7273
Signature method: Signed directly within the form
Payment Sale Number: 90573694
Payment Accounting Date: 03/11/2021
Serial Number: 90573694
Internet Transmission Date: Thu Mar 11 16:21:13 ET 2021
TEAS Stamp: USPTO/BAS-XX.XXX.XXX.XXX-202103111621139
16284-90573694-7704386b01cf3b7bc2ae6997f
066b82ce7689bde1ae629722ba136ee2c4393c1-
CC-21124095-20210311160414541943